Abstract
Cancer is one of the most aggressive diseases whose prognosis remains bleak with current therapies. The tumor microenvironment plays a significant role in the proliferation and invasion of tumor cells. In the complex tumor microenvironment, there are several types of immune-suppressing infiltrating cells, which surround the tumor and promote tumor growth and metastasis. Prostate and pancreatic cancers display tumor-infiltrating immune cells, which differentiate into cells that promote each step of the metastatic cascade and therefore are considered as novel targets for therapy. Even though several chemotherapeutic drugs are in current use for treating these cancers, tumor microenvironment targeting immunotherapeutic drugs, with minimum systemic toxic effects, are needed to save human lives from various forms of cancers. We hypothesize a safe and effective nanoinitiated drug delivery system—‘Phytochemical-conjugated gold nanoparticles,’ which can inhibit the growth and proliferation of tumor cells without affecting normal cells and at the same time boost the capability of immune system to fight cancer. There are unprecedented opportunities to advance the treatment of cancer using nanotechnology. Among the vast majority of nanoparticles, gold nanoparticles show unique properties, such as large surface-to-volume ratio, small size in the nanorealm, tunable surface chemistry, and capable of drug encapsulation. The controlled and targeted drug delivery approach makes nanoparticles very selective and effective toward cancer growth inhibition. In this chapter, we discuss the synthesis and characterization of clove phytochemical-conjugated gold nanoparticles (CP-AuNPs) and their anticancer activity against prostate (PC-3) and pancreatic cancer (PANC-1) cell lines. The synthesis and full characterization of AuNPs were confirmed by various techniques including UV–Visible spectrophotometry, transmission electron microscopy (TEM), and dynamic light-scattering (DLS) technique. We confirmed that AuNP treatment resulted in decreased cancer cell viability and enhancement in cellular internalization. These nanoparticles will navigate better to the complex tumor sites. This ‘Green Nanotechnology’ approach will be potentially effective compared to the current conventional cancer therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(a) Jemal, A., Ward, E.M., Johnson, C.J., Cronin, K.A., Ma, J., Ryerson, B., Mariotto, A., Lake, A.J., Wilson, R., Sherman, R.L., Anderson, R.N., Henley, S.J. Kohler, B.A., Penberthy, L., Feuer, E.J., Weir, H.K.: J. Natl. Cancer Inst. 109 (2017); (b) Ryerson, A.B., Eheman, C.R., Altekruse, S.F., Ward, J.W., Jemal, A., Sherman, R.L., Henley, S.J., Holtzman, D., Lake, A., Noone, A.M., Anderson, R.N., Ma, J., Ly, K.N., Cronin, K.A., Penberthy, L., Kohler, B.A.: Cancer 122, 1312–1337 (2016)
Heymach, J., Krilov, L., Alberg, A., Baxter, N., Chang, S.M., Corcoran, R., Dale, W., DeMichele, A., Magid Diefenbach, C.S., Dreicer, R., Epstein, A.S., Gillison, M.L., Graham, D.L., Jones, J., Ko, A.H., Lopez, A.M., Maki, R.G., Rodriguez-Galindo, C., Schilsky, R.L., Sznol, M., Westin, S.N., Burstein, H.: J. Clin. Oncol. 36, 1020–1044 (2018)
Moeller, B., Balagamwala, E.H., Chen, A., Creach, K.M., Giaccone, G., Koshy, M., Zaky, S., Rodrigues, G.: Pract. Radiat. Oncol. (2018)
(a) Kobayashi, S., Ueno, M., Hara, H., Irie, K., Goda, Y., Moriya, S., Tezuka, S., Tanaka, M., Okusaka, T., Ohkawa, S., Morimoto, M.: Oncology 91, 117–126 (2016); (b) Gardiner, R.F., Nicol, D.L., Green, H.J., Pakenham, K.I.: BJU Int. 98, 229–230 (2006); (c) McCann, J.: J. Natl. Cancer Inst. 92, 449–451 (2000)
Arriagada, R., Averbeck, D., Dahl, A.A., Darby, S., Fossa, S., Friberg, S., Polgar, C., de Vathaire, F.: Eur. J. Cancer 45, 354–359 (2009)
Slonina, D., Klimek, M., Szpytma, T., Gasinska, A.: Int. J. Radiat. Biol. 76, 1255–1264 (2000)
Chang, H.P., Lu, C.C., Chiang, J.H., Tsai, F.J., Juan, Y.N., Tsao, J.W., Chiu, H.Y., Yang, J.S.: Int. J. Oncol. (2018)
(a) Kaye, D.R., Min, H.S., Herrel, L.A., Dupree, J.M., Ellimoottil, C., Miller, D.C.: Oncologist (2018); (b) Bao, Y., Maciejewski, R.C., Garrido, M.M., Shah, M.A., Maciejewski, P.K., Prigerson, H.G.: J. Pain. Symptom. Manage. 55, 1113–1121 e1113 (2018)
(a) Khoobchandani, M., Katti, K., Maxwell, A., Fay, W.P., Katti, K.V.: Int. J. Mol. Sci. 17, 316 (2016); (b) Khoobchandani, M., Ganesh, N., Gabbanini, S., Valgimigli, L., Srivastava, M.M.: Fitoterapia 82, 647–653 (2011); (c) Khoobchandani, M., Ojeswi, B.K., Sharma, B., Srivastava, M.M.: Oxid. Med. Cell Longev. 2, 160–165 (2009); (d) Ojeswi, B.K., Khoobchandani, M., Hazra, D.K., Srivastava, M.M.: Hum. Exp. Toxicol. 29, 369–375 (2010); (e) Yue, Q.X., Gao, G.G., Zou, G.Y., Yu, H.Q., Zheng, X.: Biomed. Res. Int. (2017)
(a) Al-Yasiri, A.Y., Khoobchandani, M., Cutler, C.S., Watkinson, L., Carmack, T., Smith, C.J., Kuchuk, M., Loyalka, S.K., Lugao, A.B., Katti, K.V.: Dalton Trans. (2017); (b) Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R.R., Kan, P., Fent, G.M., Casteel, S.W., Smith, C.J., Boote, E., Robertson, J.D., Cutler, C., Lever, J.R., Katti, K.V., Kannan, R.: Proc. Natl. Acad. Sci. U S A 107, 8760–8765 (2010); (c) Chanda, N., Shukla, R., Katti, K.V., Kannan, R.: Nano Lett. 9, 1798–1805 (2009); (d) Chanda, N., Upendran, A., Boote, E.J., Zambre, A., Axiak, S., Selting, K., Katti, K.V., Leevy, W.M., Afrasiabi, Z., Vimal, J., Singh, J., Lattimer, J.C., Kannan, R.: J. Biomed. Nanotechnol. 10, 383–392 (2014); (e) Gamal-Eldeen, A.M., Moustafa, D., El-Daly, S.M., Abo-Zeid, M.A.M., Saleh, S., Khoobchandani, M., Katti, K., Shukla, R., Katti, K.V.: Biomed. Pharmacother. 89, 1045–1054 (2017); (f) Gamal-Eldeen, A.M., Moustafa, D., El-Daly, S.M., El-Hussieny, E.A., Saleh, S., Khoobchandani, M., Bacon, K.L., Gupta, S., Katti, K., Shukla, R., Katti, K.V.: J. Photochem. Photobiol. B 163, 47–56 (2016); (g) Katti, K., Chanda, N., Shukla, R., Zambre, A., Suibramanian, T., Kulkarni, R.R., Kannan, R., Katti, K.V.: Int. J. Green Nanotechnol. Biomed. 1, B39–B52 (2009); (h) Kattumuri, V., Katti, K., Bhaskaran, S., Boote, E.J., Casteel, S.W., Fent, G.M., Robertson, D.J., Chandrasekhar, M., Kannan, R., Katti, K.V.: Small 3, 333–341 (2007); (i) Khoobchandani, M., Katti, K., Maxwell, A., Fay, W.P., Katti, K.V.: Int. J. Mol. Sci. 17 (2016); (j) Khoobchandani, A.Z.M., Katti, K., Lin, C.H., Katti, K.V.: Int. J. Green Nanotechnol. 1, 1–15 (2013); (k) Nune, S.K., Chanda, N., Shukla, R., Katti, K., Kulkarni, R.R., Thilakavathi, S., Mekapothula, S., Kannan, R., Katti, K.V.: J. Mater. Chem. 19, 2912–2920 (2009); (l) Shukla, R., Chanda, N., Zambre, A., Upendran, A., Katti, K., Kulkarni, R.R., Nune, S.K., Casteel, S.W., Smith, C.J., Vimal, J., Boote, E., Robertson, J.D., Kan, P., Engelbrecht, H., Watkinson, L.D., Carmack, T.L., Lever, J.R., Cutler, C.S., Caldwell, C., Kannan, R., Katti, K.V.: Proc. Natl. Acad. Sci. U S A 109, 12426–12431 (2012); (m) Shukla, R., Nune, S.K., Chanda, N., Katti, K., Mekapothula, S., Kulkarni, R.R., Welshons, W.V., Kannan, R., Katti, K.V.: Small 4, 1425–1436 (2008); (n) Silva, R.A., Giordano, R.J., Gutierrez, P.S., Rocha, V.Z., Rudnicki, M., Kee, P., Abdalla, D.S., Puech-Leao, P., Caramelli, B., Arap, W., Pasqualini, R., Meneghetti, J.C., Marques, F.L., Khoobchandani, M., Katti, K.V., Lugao, A.B., Kalil, J.: Int. J. Mol. Sci. 17 (2016)
Dreaden, E.C., Austin, L.A., Mackey, M.A., El-Sayed, M.A.: Ther Deliv 3, 457–478 (2012)
(a) Langston Suen, W.L., Chau, Y.: J. Pharm. Pharmacol. 66, 564–573 (2014); (b) Shan, Y., Ma, S., Nie, L., Shang, X., Hao, X., Tang, Z., Wang, H.: Chem. Commun. (Camb) 47, 8091–8093 (2011)
Nichols, J.W., Bae, Y.H.: Nano Today 7, 606–618 (2012)
Cortes-Rojas, D.F., de Souza, C.R., Oliveira, W.P.: Asian Pac J Trop Biomed 4, 90–96 (2014)
Milczarek, G., Ciszewski, A.: Colloids Surf. B Biointerfaces 90, 53–57 (2012)
Liu, X., Atwater, M., Wang, J., Huo, Q.: Colloids Surf. B Biointerfaces 58, 3–7 (2007)
Tsai, T.H., Huang, W.C., Lien, T.J., Huang, Y.H., Chang, H., Yu, C.H., Tsai, P.J.: Food Agric. Immunol. 28, 916–931 (2017)
Islamuddin, M., Chouhan, G., Want, M.Y., Ozbak, H.A., Hemeg, H.A., Afrin, F.: Plos Neglected Trop. Dis. 10 (2016)
Acknowledgements
We thank the Institute of Green Nanotechnology for supporting this interdisciplinary research. We also thank the University of Missouri Departments of Radiology and School of Medicine for financial support.
Author Contributions
Menka Khoobchandani, Kavita K. Katti, and Kattesh V. Katti conceived and designed experiments, analyzed data, and edited the manuscript. Menka Khoobchandani performed the experiments, analyzed and observed the data, and wrote the paper. Kavita K. Katti and Alice Raphael Karikachery edited the manuscript. Velaphi C. Thipe reviewed the manuscript. Pierce L.R. Bloebaum analyzed and performed nanoparticles calculation.
Conflicts of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Khoobchandani, M., Katti, K.K., Karikachery, A.R., Thipe, V., Bloebaum, P., Katti, K.V. (2019). Targeted Phytochemical-Conjugated Gold Nanoparticles in Cancer Treatment. In: Khoobchandani, M., Saxena, A. (eds) Biotechnology Products in Everyday Life. EcoProduction. Springer, Cham. https://doi.org/10.1007/978-3-319-92399-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-92399-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92398-7
Online ISBN: 978-3-319-92399-4
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)